Skip Navigation


Mol. Hum. Reprod. Advance Access originally published online on April 22, 2005
Molecular Human Reproduction 2005 11(5):357-360; doi:10.1093/molehr/gah175
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
11/5/357    most recent
gah175v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sata, F.
Right arrow Articles by Kishi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sata, F.
Right arrow Articles by Kishi, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Molecular Human Reproduction © The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions{at}oupjournals.org

Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss

Fumihiro Sata1,3, Hideto Yamada2, Kana Suzuki1, Yasuaki Saijo1, Emi H Kato2, Mamoru Morikawa2, Hisanori Minakami2 and Reiko Kishi1

1Department of Public Heath and 2Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638, Japan

3 To whom correspondence should be addressed. Email: fsata{at}med.hokudai.ac.jp

Some case–control studies have demonstrated that caffeine intake and high CYP1A2 activity increase risks of recurrent pregnancy loss (RPL) but the multifactorial effect is obscure. To investigate whether susceptible women who have more caffeine intake are at high risk of RPL, a case–control study of 58 cases with two or more RPL and fertile 147 controls was performed. The association between daily caffeine intake together with CYP1A2*1F (AA versus CA and CC) genotype and RPL was assessed. Without consideration of the genotype, there were no significant differences of the RPL risk in proportion to daily caffeine intake [less than 100 mg (reference); 100–299 mg: odds ratio (OR), 1.29; 95% confidence interval (CI), 0.66–2.50; 300 mg or more: OR, 1.82; 95% CI, 0.72–4.58; P for trend, 0.20]. However, the RPL risk significantly increased only among women who had homozygous CYP1A2*1F alleles with a dosage effect of daily caffeine intake [less than 100 mg (reference); 100–299 mg: OR, 1.94; 95% CI, 0.57–6.66; 300 mg or more: OR, 5.23; 95% CI, 1.05–25.9; P for trend, 0.03]. It was demonstrated for the first time that an increase in caffeine intake deteriorates the fecundity among susceptible women.

Key words: caffeine/CYP1A2/genetic polymorphism/molecular epidemiology/recurrent pregnancy loss


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.